Barbie Taylor‐Harding
Cedars-Sinai Medical Center(US)University of California, Los Angeles(US)
Publications by Year
Research Areas
Cancer-related Molecular Pathways, Ovarian cancer diagnosis and treatment, Epigenetics and DNA Methylation, Cancer Mechanisms and Therapy, Cancer Cells and Metastasis
Most-Cited Works
- → Native E2F/RBF Complexes Contain Myb-Interacting Proteins and Repress Transcription of Developmentally Controlled E2F Target Genes(2004)284 cited
- → A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets(2016)134 cited
- → VEGFR3 Inhibition Chemosensitizes Ovarian Cancer Stemlike Cells through Down-Regulation of BRCA1 and BRCA2(2014)130 cited
- → Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS(2014)119 cited
- → Cyclin E as a potential therapeutic target in high grade serous ovarian cancer(2016)96 cited
- → Drosophila E2F1 Has Context-Specific Pro- and Antiapoptotic Properties during Development(2005)78 cited
- → Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors(2020)71 cited
- → Liver X receptor agonist inhibits proliferation of ovarian carcinoma cells stimulated by oxidized low density lipoprotein(2009)71 cited
- → p55, the Drosophila Ortholog of RbAp46/RbAp48, Is Required for the Repression of dE2F2/RBF-Regulated Genes(2004)68 cited
- → Screening cell mechanotype by parallel microfiltration(2015)56 cited